A population-based study of the effectiveness of stereotactic ablative radiotherapy versus conventional fractionated radiotherapy for clinical stage I non-small cell lung cancer patients

• Main Authors: Tu Chih-Yen, Hsia Te-Chun, Fang Hsin-Yuan, Liang Ji-An, Yang Su-Tso, Li Chia-Chin, Chien Chun-Ru
• Format: Article
• Language: English
• Published: Sciendo 2017-12-01
• Series: Radiology and Oncology
• Subjects: stereotactic ablative radiotherapy; conventional fractionated radiotherapy; non-small cell lung cancer
• Online Access: https://doi.org/10.1515/raon-2017-0058
• ISSN: 1581-3207

Stereotactic ablative radiotherapy (SABR) is a promising option for non-operated early-stage non-small cell lung cancer (NSCLC) compared to conventional fractionated radiotherapy (CFRT). However, results from conclusive randomized controlled trials are not yet available. The aim of our study was to explore the effectiveness of SABR vs. CFRT for non-operated early-stage NSCLC.